Dr. Marina Udier comments the Neoantigen vaccine report card issued by BioCentury By fabiocrognale Posted 12/07/2022 In External Presentations Dr. Marina Udier comments the Neoantigen vaccine report card issued by BioCentury2022-12-072022-12-07http://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.pngNouscomhttp://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.png200px200px Please find the full report below: Download full PDF Recent PostsNouscom announces appointment of Yen Ching as Vice President of Clinical OperationsNouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal CancerNouscom Announces First Patient Dosed in Phase 2 Randomized Trial with NOUS-209, an ‘off-the shelf’ Neoantigen Cancer Immunotherapy in dMMR/MSI-High Metastatic Colorectal CancerNouscom’s Personalized Neoantigen Cancer Immunotherapy NOUS-PEV Demonstrates Promising Safety, Immunogenicity and Anti-tumor Activity in Solid Tumors
